Similar articles

• [Human leukocyte interferon for clinical trials (author's transl)].

  Matsuo A. Matsuo A. Tanpakushitsu Kakusan Koso. 1976 Apr;21(4):296-300. Tanpakushitsu Kakusan Koso. 1976. PMID: 796879 Review. Japanese. No abstract available.
• Interferon production by leukocytes cultures from neoplastic patients.

  Cortada de de la Peña N, de Lustig ES. Cortada de de la Peña N, et al. Eur J Cancer (1965). 1974 Mar;10(3):189-92. doi: 10.1016/0014-2964(74)90153-4. Eur J Cancer (1965). 1974. PMID: 4372047 No abstract available.
• [Production of human type I interferon by lymphocytes in contact with cells infected by herpesvirus and fixed with glutaraldehyde].

  Lebon P, Commoy-Chevalier MJ, Robert-Galliot B, Morin A, Chany C. Lebon P, et al. C R Seances Acad Sci D. 1980 Jan 7;290(1):37-40. C R Seances Acad Sci D. 1980. PMID: 6156022 French.
• [Comparative study on the antiviral sensitivities of various cell lines to various interferons (author's transl)].

  Pak CB, Imanishi J, Kishida T, Matsuo A, Tanimoto T. Pak CB, et al. Uirusu. 1979 Dec;29(2):149-51. Uirusu. 1979. PMID: 95140 Japanese. No abstract available.
• [Interferon production in vivo and immune system (author's transl)].

  Kunii A. Kunii A. Tanpakushitsu Kakusan Koso. 1976 Apr;21(4):315-21. Tanpakushitsu Kakusan Koso. 1976. PMID: 796882 Review. Japanese. No abstract available.